Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Humanin and BAC Water Mix

Humanin Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Humanin Titration Schedule

ItemDetails
HNG dose0.5–2 mg SC once daily (AM)
FrequencyDaily or every other day
Cycle8–12 weeks + 4–8 off

Dose range matches the community standard for the S14G analog (HNG), which is ~1000× more potent than native humanin. Cycling is admittedly precautionary — natural humanin is constant; no human trial of exogenous dosing exists. Animal protocol: 4 mg/kg twice weekly.

Possible vial strengths:

What Is It?

Humanin

Mitochondrial-derived peptide.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Humanin

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Humanin Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Humanin is a 24-amino-acid peptide that's unusual in being encoded inside mitochondrial DNA (the MT-RNR2 region) rather than the cell nucleus, and it was the first of the "mitochondrial-derived peptides" ever identified. It was discovered in 2001 in the surviving neurons of an Alzheimer's patient, and its core job is cytoprotection — chiefly by blocking the pro-apoptotic protein BAX to stop cells from dying, alongside binding IGFBP-3 and switching on STAT3 survival signaling. It's studied for neuroprotection, heart protection, insulin sensitivity, and longevity, though the evidence so far is preclinical.
It comes as a lyophilized powder, so add bacteriostatic water down the vial wall, swirl gently, and don't shake. As a worked example, a 10 mg vial with 3 mL of bacteriostatic water gives 3.33 mg/mL, so a 1.5 mg dose would be 0.45 mL — 45 units on a U-100 insulin syringe. Because there are no human dose-ranging studies, treat any figure like this as extrapolated from animal work rather than an established amount.
All three get grouped as "mitochondrial peptides," but they aren't the same kind of thing. Humanin and MOTS-c are both mitochondrial-derived peptides — Humanin is a 24-residue cytoprotective, anti-apoptotic peptide from the 16S rRNA region, while MOTS-c is a shorter 16-residue peptide from the 12S rRNA region that's more about metabolism and AMPK signaling. SS-31 (elamipretide) is a different beast entirely: a synthetic tetrapeptide that isn't mitochondria-encoded at all and works by binding cardiolipin to stabilize the inner mitochondrial membrane.
S14G-Humanin — also written HNG or [Gly14]-Humanin — is an engineered version of Humanin with a single change: serine swapped for glycine at position 14. That one substitution makes it roughly 1000 times more potent than natural Humanin across the neuroprotective, cardioprotective, and metabolic effects that have been studied. In practice that means it isn't dosed like plain Humanin at all, and a lot of the more striking animal data — including cognitive-decline work — actually used HNG rather than the wild-type peptide.
Humanin has no completed human trials and no established safety profile, so it should be treated as an early-stage research compound that isn't FDA-approved. The specific thing worth flagging is its mechanism: because Humanin works by preventing apoptosis (programmed cell death), the same cytoprotection that looks beneficial for neurons could in theory also shield cancer cells, and it has been studied on both sides of that question. That anti-apoptotic double edge, together with the absence of human data, is the reason to be cautious rather than assume it's harmless.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides